Insider · CIK 0001716213

Hamill John P.

Reports to the SEC for 4 companies · DOYLESTOWN, PA

sec.gov

Transactions

Companies

Filings

CIK

0001716213

Forms 4 and 5

Insider transactions

33 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-03-31	APREAprea Therapeutics, Inc. · Pre-Funded WarrantP Purchase	SrVP/CFO/Prin Fin & Acct Ofcr	PPurchase	+31K sh	$0.81	+$25K	30,978
2026-03-31	APREAprea Therapeutics, Inc. · Common WarrantP Purchase	SrVP/CFO/Prin Fin & Acct Ofcr	PPurchase	+31K sh	—	—	30,978
2026-03-12	APREAprea Therapeutics, Inc.A Award	SrVP/CFO/Prin Fin & Acct Ofcr	AAward	+10.1K sh	—	—	43,528
2026-03-12	APREAprea Therapeutics, Inc. · Stock Options (Right to Buy)A Award	SrVP/CFO/Prin Fin & Acct Ofcr	AAward	+40.4K sh	—	—	40,380
2026-01-30	APREAprea Therapeutics, Inc.P Purchase	SrVP/CFO/Prin Fin & Acct Ofcr	PPurchase	+5,700 sh	$0.89	+$5,073	33,433
2026-01-30	APREAprea Therapeutics, Inc. · Common WarrantP Purchase	SrVP/CFO/Prin Fin & Acct Ofcr	PPurchase	+5,700 sh	—	—	5,700
2025-12-10	APREAprea Therapeutics, Inc.P Purchase	SrVP/CFO/Prin Fin & Acct Ofcr	PPurchase	+5,000 sh	$1.17	+$5,825	27,733
2025-12-10	APREAprea Therapeutics, Inc. · Common WarrantP Purchase	SrVP/CFO/Prin Fin & Acct Ofcr	PPurchase	+5,000 sh	—	—	5,000
2025-03-27	APREAprea Therapeutics, Inc.A Award	SrVP/CFO/Prin Fin & Acct Ofcr	AAward	+3,365 sh	—	—	22,733
2025-03-27	APREAprea Therapeutics, Inc. · Stock Options (Right to Buy)A Award	SrVP/CFO/Prin Fin & Acct Ofcr	AAward	+13.5K sh	—	—	13,460
2024-10-11	APREAprea Therapeutics, Inc.P Purchase	SrVP/CFO/Prin Fin & Acct Ofcr	PPurchase	+50 sh	$2.46	+$123.19	19,368
2024-10-10	APREAprea Therapeutics, Inc.P Purchase	SrVP/CFO/Prin Fin & Acct Ofcr	PPurchase	+450 sh	$2.61	+$1,174.5	19,318
2024-03-28	APREAprea Therapeutics, Inc.A Award	SrVP/CFO/Prin Fin & Acct Ofcr	AAward	+3,365 sh	—	—	18,868
2024-03-28	APREAprea Therapeutics, Inc. · Stock Options (Right to Buy)A Award	SrVP/CFO/Prin Fin & Acct Ofcr	AAward	+13.5K sh	—	—	13,460
2024-03-13	APREAprea Therapeutics, Inc.P Purchase	SrVP/CFO/Prin Fin & Acct Ofcr	PPurchase	+1,010 sh	$7.29	+$7,362.9	15,503
2024-03-13	APREAprea Therapeutics, Inc. · Tranche A WarrantP Purchase	SrVP/CFO/Prin Fin & Acct Ofcr	PPurchase	+505 sh	—	—	505
2024-03-13	APREAprea Therapeutics, Inc. · Tranche B WarrantP Purchase	SrVP/CFO/Prin Fin & Acct Ofcr	PPurchase	+505 sh	—	—	505
2023-02-27	APREAprea Therapeutics, Inc.A Award	SrVP/CFO/Prin Fin & Acct Ofcr	AAward	+1,000 sh	$5.25	+$5,250	14,493
2023-01-30	APREAprea Therapeutics, Inc.A Award	SrVP/CFO/Prin Fin & Acct Ofcr	AAward	+270K sh	—	—	269,879
2023-01-30	APREAprea Therapeutics, Inc. · Employee Stock Option (Right to Buy)A Award	SrVP/CFO/Prin Fin & Acct Ofcr	AAward	+540K sh	—	—	539,758
2022-07-26	WINTWINDTREE THERAPEUTICS INC /DE/P Purchase	SVP & CFO	PPurchase	+3,000 sh	$0.37	+$1,099.8	72,800
2022-03-04	WINTWINDTREE THERAPEUTICS INC /DE/A Award	SVP & CFO	AAward	+66.3K sh	—	—	69,800
2022-03-04	WINTWINDTREE THERAPEUTICS INC /DE/ · Employee Stock Option (Right to Buy)A Award	SVP & CFO	AAward	+99.6K sh	—	—	99,600
2021-04-16	WINTWINDTREE THERAPEUTICS INC /DE/P Purchase	SVP & CFO	PPurchase	+1,000 sh	$2.07	+$2,066.9	3,500
2021-03-25	WINTWINDTREE THERAPEUTICS INC /DE/P Purchase	SVP & CFO	PPurchase	+1,500 sh	$3.25	+$4,875	2,500
2021-03-25	WINTWINDTREE THERAPEUTICS INC /DE/ · Common Stock WarrantsP Purchase	SVP & CFO	PPurchase	+1,500 sh	—	—	1,500
2021-01-22	WINTWINDTREE THERAPEUTICS INC /DE/ · Employee Stock Option (Right to Buy)A Award	SVP & CFO	AAward	+60K sh	—	—	60,000
2020-10-07	WINTWINDTREE THERAPEUTICS INC /DE/P Purchase	SVP & CFO	PPurchase	+1,000 sh	$5.27	+$5,270	1,000
2020-07-20	WINTWINDTREE THERAPEUTICS INC /DE/ · Non-Qualified Stock Option (Right to Buy)A Award	SVP & CFO	AAward	+211K sh	—	—	211,000
2019-06-03	TREVENA INCF Tax Payment	VP Fin,Princ Fin&Acct Officer	FTax Payment	−5,516 sh	$1.17	−$6,453.72	82,234
2019-05-31	TREVENA INCP Purchase	VP Fin,Princ Fin&Acct Officer	PPurchase	+7,500 sh	$1.16	+$8,700	87,750
2018-12-06	TREVENA INCA Award	VP Fin,Princ Fin&Acct Officer	AAward	+80K sh	—	—	80,250
2018-08-31	TREVENA INCStock Option (Right to Buy)A Award	VP Fin,Princ Fin&Acct Officer	AAward	+52.5K sh	—	—	52,500

Recent filings

Accepted (ET)
Apr 14
Hamill John P.0001104659-26-038522
SEC(opens sec.gov)
Mar 164
Hamill John P.0001104659-26-028653
SEC(opens sec.gov)
Feb 24
Hamill John P.0001104659-26-009203
SEC(opens sec.gov)
Dec 114
Hamill John P.0001104659-25-120155
SEC(opens sec.gov)
Mar 314
Hamill John P.0001104659-25-029920
SEC(opens sec.gov)
Oct 164
Hamill John P.0001104659-24-108962
SEC(opens sec.gov)
Oct 154
Hamill John P.0001104659-24-108373
SEC(opens sec.gov)
Mar 284
Hamill John P.0001104659-24-040645
SEC(opens sec.gov)
Mar 144
Hamill John P.0001104659-24-034673
SEC(opens sec.gov)
Feb 274
Hamill John P.0001104659-23-026159
SEC(opens sec.gov)
Jan 304
Hamill John P.0001104659-23-008064
SEC(opens sec.gov)

Companies

Address

3805 OLD EASTON ROAD

DOYLESTOWN, PA, 18902